Topic: obstructive sleep apnea
The sleep apnea specialist wants the cash to step up commercialization of its FDA-approved neurostimulation device.
LivaNova will pay $78 million and commit to almost $150 million more to buy the rest of ImThera and its neurostimulation treatment for sleep apnea.
Somnarus presented a study showing that its disposable adhesive patch effectively detected obstructive sleep apnea.
Nyxoah, which is working on a neurostimulation-based therapy for obstructive sleep apnea, announced Thursday that it raised €18 million ($20 million).
NightBalance has picked up €12.5 million in a Series B round led by INKEF Capital and Gilde Healthcare Partners.